BiomarkersHumans
CHANGE IN ALZHEIMER’S DISEASE BLOOD-BASED BIOMARKERS AND ASSOCIATIONS WITH BRAIN AMYLOID DEPOSITION
GSA 2024 Abstract
Abstract
Blood-based biomarkers show promise as a noninvasive, inexpensive method for measuring Alzheimer’s disease pathology throughout the lifecourse.
The paper
New York University · University of North Carolina at Chapel Hill
GSA 2024 Abstract · 31 Dec 2024 · CC BY
Presented at GSA 2024
